Geode Capital Management
TCON

Geode Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-286,709
Closed -$123K 4639
2024
Q1
$123K Buy
286,709
+77,923
+37% +$33.5K ﹤0.01% 4098
2023
Q4
$36.6K Sell
208,786
-4,437
-2% -$777 ﹤0.01% 4421
2023
Q3
$38K Buy
213,223
+57,397
+37% +$10.2K ﹤0.01% 4486
2023
Q2
$45.3K Hold
155,826
﹤0.01% 4524
2023
Q1
$295K Hold
155,826
﹤0.01% 3867
2022
Q4
$232K Sell
155,826
-332
-0.2% -$494 ﹤0.01% 4023
2022
Q3
$260K Hold
156,158
﹤0.01% 4053
2022
Q2
$312K Buy
156,158
+3,098
+2% +$6.19K ﹤0.01% 4012
2022
Q1
$402K Buy
153,060
+9,148
+6% +$24K ﹤0.01% 4056
2021
Q4
$398K Sell
143,912
-1,833
-1% -$5.07K ﹤0.01% 4161
2021
Q3
$564K Buy
145,745
+7,923
+6% +$30.7K ﹤0.01% 3974
2021
Q2
$894K Buy
137,822
+32,868
+31% +$213K ﹤0.01% 3661
2021
Q1
$863K Buy
104,954
+36,273
+53% +$298K ﹤0.01% 3614
2020
Q4
$803K Buy
+68,681
New +$803K ﹤0.01% 3432
2019
Q4
Sell
-97,673
Closed -$43K 4243
2019
Q3
$43K Hold
97,673
﹤0.01% 4082
2019
Q2
$66K Buy
97,673
+40,699
+71% +$27.5K ﹤0.01% 4039
2019
Q1
$78K Hold
56,974
﹤0.01% 3943
2018
Q4
$35K Hold
56,974
﹤0.01% 4043
2018
Q3
$116K Hold
56,974
﹤0.01% 3900
2018
Q2
$153K Buy
56,974
+29,917
+111% +$80.3K ﹤0.01% 3784
2018
Q1
$62K Hold
27,057
﹤0.01% 3922
2017
Q4
$90K Hold
27,057
﹤0.01% 3843
2017
Q3
$85K Hold
27,057
﹤0.01% 3850
2017
Q2
$64K Sell
27,057
-1,653
-6% -$3.91K ﹤0.01% 3918
2017
Q1
$107K Buy
28,710
+222
+0.8% +$827 ﹤0.01% 3818
2016
Q4
$139K Buy
28,488
+4,031
+16% +$19.7K ﹤0.01% 3716
2016
Q3
$165K Buy
24,457
+37
+0.2% +$250 ﹤0.01% 3663
2016
Q2
$106K Hold
24,420
﹤0.01% 3787
2016
Q1
$170 Sell
24,420
-37
-0.2% ﹤0.01% 3684
2015
Q4
$225K Buy
24,457
+4,831
+25% +$44.4K ﹤0.01% 3637
2015
Q3
$191K Buy
19,626
+1,209
+7% +$11.8K ﹤0.01% 3695
2015
Q2
$208K Buy
+18,417
New +$208K ﹤0.01% 3574